Related Articles

• Dual specific CD19/CD22‑targeted chimeric antigen receptor T‑cell therapy for refractory diffuse large B‑cell lymphoma: A case report
• Anti‑BCMA CAR‑T cell immunotherapy for relapsed or refractory multiple myeloma
• Efficacy of emapalumab in the management of anti‑CD19 chimeric antigen receptor T‑cell therapy‑associated cytokine release syndrome: A report of two cases
• CAR‑T 19 combined with reduced‑dose PD‑1 blockade therapy for treatment of refractory follicular lymphoma: A case report
• A phase I study of CAR‑T bridging HSCT in patients with acute CD19⁺ relapse/refractory B‑cell leukemia